| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 6.195 | 20.628 | 27.598 | 24.288 | 43.885 |
| Total Income - EUR | 157 | 356 | 306 | 64 | 0 | 6.195 | 20.628 | 27.598 | 24.288 | 43.885 |
| Total Expenses - EUR | 130 | 309 | 263 | 21 | 816 | 1.934 | 13.731 | 6.085 | 19.173 | 41.622 |
| Gross Profit/Loss - EUR | 28 | 47 | 44 | 43 | -816 | 4.261 | 6.897 | 21.513 | 5.115 | 2.263 |
| Net Profit/Loss - EUR | 23 | 37 | 35 | 41 | -816 | 4.081 | 6.278 | 20.833 | 4.928 | 943 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Damident Clinique Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 42 | 0 | 0 | 0 | 10.465 | 15.341 | 12.506 | 10.062 | 21.606 | 55.077 |
| Current Assets | 98 | 159 | 211 | 177 | 6.667 | 11.389 | 2.880 | 11.750 | 4.729 | 3.545 |
| Inventories | 0 | 0 | 0 | 0 | 4.089 | 5.726 | 0 | 0 | 594 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 1.996 | 4.949 | 1.797 | 2.338 | 31 | 86 |
| Cash | 98 | 159 | 211 | 177 | 582 | 714 | 1.083 | 9.413 | 4.104 | 3.458 |
| Shareholders Funds | 68 | 104 | 137 | 175 | -644 | 3.449 | 9.651 | 20.882 | 25.746 | 22.936 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 72 | 55 | 75 | 2 | 17.776 | 23.280 | 5.735 | 930 | 589 | 35.686 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Damident Clinique Srl